Gerri Henwood
2013 - Recro Pharma
In 2013, Gerri Henwood earned a total compensation of $125K as President and Chief Executive Officer at Recro Pharma.
Compensation breakdown
| Salary | $125,000 |
|---|---|
| Total | $125,000 |
Henwood received $125K in salary, accounting for 100% of the total pay in 2013.
Rankings
In 2013, Gerri Henwood's compensation ranked 11,996th out of 12,286 executives tracked by ExecPay. In other words, Henwood earned more than 2.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,996 out of 12,286 | 2nd |
Division Manufacturing | 4,497 out of 4,612 | 3rd |
Major group Chemicals And Allied Products | 1,430 out of 1,466 | 3rd |
Industry group Drugs | 1,134 out of 1,160 | 2nd |
Industry Pharmaceutical Preparations | 871 out of 890 | 2nd |
Source: SEC filing on April 29, 2015.
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019